Media Summary: Matt Kinn, Senior Vice President of Business Development discusses Our first-ever public Map demonstration dives into our process and software for navigating complex biological and chemical ... In this episode, Ed is joined by Ben Taylor, Chief Financial Officer and President of

Recursion And Genentech Present At - Detailed Analysis & Overview

Matt Kinn, Senior Vice President of Business Development discusses Our first-ever public Map demonstration dives into our process and software for navigating complex biological and chemical ... In this episode, Ed is joined by Ben Taylor, Chief Financial Officer and President of Making change, especially in drug discovery, requires a different approach, a willingness to be bold and to double-down on ... Chief Technology Officer Ben Mabey announces

Photo Gallery

Recursion and Genentech Present at the LMRL Workshop at NeurIPS 2022
Behind Recursion's Transformational Partnership with Roche and Genentech
Download Day 2023 — Recursion's Partnerships with Roche/Genentech and Bayer
How Recursion Is Collaborating with Bayer on the Next Generation of Cancer Treatments
Highlights from Recursion's TechBio Talks Live Event at the 2026 J.P. Morgan Healthcare Conference
Recursion's Mapping & Navigating Demonstration
Download Day 2023 — State of Drug Discovery & State of Recursion by Chris Gibson, Co-founder & CEO
How Recursion Is Using AI to Rethink Drug Discovery
AI & Computational Biology With Recursion's Chris Gibson, Ph.D.
Talking Neurons and Taking Risks - Andrew Taibi, Process Development Scientist at Recursion
Download Day 2023 — Recursion CTO Ben Mabey announces MolRec application and RxRx3 Dataset
This is a Better Way to Understand Recursion
View Detailed Profile
Recursion and Genentech Present at the LMRL Workshop at NeurIPS 2022

Recursion and Genentech Present at the LMRL Workshop at NeurIPS 2022

On December 9, 2022,

Behind Recursion's Transformational Partnership with Roche and Genentech

Behind Recursion's Transformational Partnership with Roche and Genentech

In December 2021,

Download Day 2023 — Recursion's Partnerships with Roche/Genentech and Bayer

Download Day 2023 — Recursion's Partnerships with Roche/Genentech and Bayer

Matt Kinn, Senior Vice President of Business Development discusses

How Recursion Is Collaborating with Bayer on the Next Generation of Cancer Treatments

How Recursion Is Collaborating with Bayer on the Next Generation of Cancer Treatments

The Bayer -

Highlights from Recursion's TechBio Talks Live Event at the 2026 J.P. Morgan Healthcare Conference

Highlights from Recursion's TechBio Talks Live Event at the 2026 J.P. Morgan Healthcare Conference

Recursion

Recursion's Mapping & Navigating Demonstration

Recursion's Mapping & Navigating Demonstration

Our first-ever public Map demonstration dives into our process and software for navigating complex biological and chemical ...

Download Day 2023 — State of Drug Discovery & State of Recursion by Chris Gibson, Co-founder & CEO

Download Day 2023 — State of Drug Discovery & State of Recursion by Chris Gibson, Co-founder & CEO

Recursion's

How Recursion Is Using AI to Rethink Drug Discovery

How Recursion Is Using AI to Rethink Drug Discovery

In this episode, Ed is joined by Ben Taylor, Chief Financial Officer and President of

AI & Computational Biology With Recursion's Chris Gibson, Ph.D.

AI & Computational Biology With Recursion's Chris Gibson, Ph.D.

Recursion's

Talking Neurons and Taking Risks - Andrew Taibi, Process Development Scientist at Recursion

Talking Neurons and Taking Risks - Andrew Taibi, Process Development Scientist at Recursion

Making change, especially in drug discovery, requires a different approach, a willingness to be bold and to double-down on ...

Download Day 2023 — Recursion CTO Ben Mabey announces MolRec application and RxRx3 Dataset

Download Day 2023 — Recursion CTO Ben Mabey announces MolRec application and RxRx3 Dataset

Chief Technology Officer Ben Mabey announces

This is a Better Way to Understand Recursion

This is a Better Way to Understand Recursion

People often explain

How Recursion Used AI to Find a Novel Way to Potentially Treat a Debilitating Rare Disease

How Recursion Used AI to Find a Novel Way to Potentially Treat a Debilitating Rare Disease

A new video shares the story of